Search

everythinglearnresearchcommunity

for

Search:↓

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

OR-101 shows promise for treating alopecia areata by improving hair growth.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

miR-203a-3p helps hair follicle stem cells become specialized by targeting Smad1.

A 72-year-old man was diagnosed with a rare skin form of Rosai-Dorfman disease after years of misdiagnosis.

BerEP4 and CD34 staining can help tell apart tricholemmoma from basal cell carcinoma.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

DAB labeling effectively identifies collagen type III and PDGFR in horse skin, but may show false positives.

CCCA may involve the PD1/PDL1 pathway and increased caspase 3, leading to permanent hair loss.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

CD4+ skin cells may be precursors to basal cell carcinoma.

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

Topical IKKα inhibitors may help prevent CCS tumours.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Targeting ornithine decarboxylase can help prevent skin cancer.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

Enhancing Tregs can protect against alopecia areata.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

Mouse skin cancer progression involves a unique group of cells marked by ABCG2 and MTS24.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.